Presentation is loading. Please wait.

Presentation is loading. Please wait.

High neutrophil-to-lymphocyte ratio before starting anti-programmed cell death 1 immunotherapy predicts poor outcome in patients with metastatic melanoma 

Similar presentations


Presentation on theme: "High neutrophil-to-lymphocyte ratio before starting anti-programmed cell death 1 immunotherapy predicts poor outcome in patients with metastatic melanoma "— Presentation transcript:

1 High neutrophil-to-lymphocyte ratio before starting anti-programmed cell death 1 immunotherapy predicts poor outcome in patients with metastatic melanoma  Margaux Garnier, MD, Julia Zaragoza, MD, Nathalie Bénéton, MD, Guido Bens, MD, Victoire Meurisse, MD, Mahtab Samimi, MD, PhD, Hervé Maillard, MD, Laurent Machet, MD, PhD  Journal of the American Academy of Dermatology  Volume 79, Issue 1, Pages e2 (July 2018) DOI: /j.jaad Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

2 Supplemental Fig 1 Kaplan–Meier curves for progression-free survival (A) and overall survival (B) by drug used (nivolumab or pembrolizumab). Journal of the American Academy of Dermatology  , e2DOI: ( /j.jaad ) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions

3 Supplemental Fig 2 Kaplan–Meier curves for progression-free survival (A) and overall survival (B) by NLR. NLR, Neutrophil-to-lymphocyte ratio; PD1, programmed cell death 1. Journal of the American Academy of Dermatology  , e2DOI: ( /j.jaad ) Copyright © 2018 American Academy of Dermatology, Inc. Terms and Conditions


Download ppt "High neutrophil-to-lymphocyte ratio before starting anti-programmed cell death 1 immunotherapy predicts poor outcome in patients with metastatic melanoma "

Similar presentations


Ads by Google